Bullish
Penumbra, Inc. announced it has received U.S. FDA clearance for THUNDERBOLT, expanding its computer assisted vacuum thrombectomy (CAVT) technology to ...
Neutral
This article presents the balance sheet information for Penumbra, Inc. (XETR:0P8). As of Q1 2026, the company's total assets are 1.64 billion EUR, sho...
Bearish
This article provides a technical analysis of Penumbra Inc. (PEN) stock, indicating a "Sell" consensus based on various indicators. It details momentu...